BCRX
NASD BioCryst Pharmaceuticals, Inc.$8.22 ↓ -0.05 (-0.67%) Trading Down from the previous close of $8.27, $0.17 below the day’s high of $8.39
- YTD change
- +5.32%
- vs 20-day SMA
- -6.95%
- vs 200-day SMA
- -5.27%
Price ranges
Price & Performance
-1.18 (-12.49%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 58.9% away from all-time highs of $19.99
- BCRX is up 5% since the beginning of the year
- BCRX is up 8% over the past 12 months
- BCRX is down 15% over the past 1 month
- 16% of all BCRX investors are betting against BCRX
BCRX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +9.0%.
- Previous minute
- -$0.01
- Last hour
- -$0.07
- Last 5 days
- -6.44%
- vs 8-day SMA
- -4.25%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.